إنتاج وتنقية الإنترفيرون
In modern medicine, biopharmaceuticals have brought significant breakthroughs in treating diseases. Interferon (IFN) is a key autocrine and paracrine protein that exhibits broad therapeutic efficacy against various conditions.
IFN has a tremendous impact on the global therapeutic protein market. The interferon market experienced substantial growth, reaching $6.9 billion in 2019, and it is projected to continue growing in the future due to factors such as the rising incidence of chronic diseases.
Classification and Mechanism of Interferon
Interferon is classified into types α, β, γ, among others, as well as Types I-III, which bind to specific receptors to trigger different signaling pathways and immune responses. IFN is clinically used for immune responses against infections and the treatment of autoimmune diseases, cancer, etc., by regulating gene expression and influencing cell metabolism and differentiation.
Production of Therapeutic Cloned Interferon
عملية المنبع
Escherichia coli (E. coli) is often the preferred choice due to its rapid growth and cost-effectiveness, expressing interferon through periplasmic secretion, cytoplasmic soluble expression, or as inclusion bodies. Pichia pastoris can achieve high-cell-density expression, relying on the AOX promoter, with co-expression of molecular chaperones and codon optimization enhancing translation efficiency.
عملية المصب
Downstream processing involves extracting the target protein from cells or culture supernatants and purifying it. In E. coli, interferon can be obtained via the periplasmic or cytoplasmic pathway or as inclusion bodies. Chromatographic methods include affinity chromatography, ion-exchange chromatography, size-exclusion chromatography, etc. To overcome the challenges of traditional chromatography, alternative methods such as aqueous two-phase systems, reverse micellar extraction, and immunomagnetic microspheres have been investigated.
Formulation and Delivery of Interferon
Interferon is primarily administered through subcutaneous injection. To improve pharmacokinetics, stabilizers/excipients, pegylation, and encapsulation in drug delivery systems such as liposomes and nanoparticles are used. Novel delivery systems aim to reduce invasiveness and improve patient compliance, but further research is needed on their pharmacokinetics and therapeutic effects.
وفي الختام
IFN, vital in human cell defense, fights viruses, cancer, and neurodegenerative diseases. Since 1986, 22 formulations have been approved. Traditional chromatography, widely used in downstream processing, faces challenges, needing alternative methods. Future biosimilars will offer new interferon therapy opportunities, requiring efficacy-enhancing strategies.
Yaohai Bio-Pharma specializes in providing one-stop outsourcing services for the fermentation, purification, formulation development, and production of a series of interferons using Escherichia coli and yeast expression systems. We can guarantee to meet our clients' customized interferon requirements in the fast delivery time.
كما تسعى شركة Yaohai Bio-Pharma بنشاط إلى استقطاب شركاء عالميين من المؤسسات أو الأفراد وتقدم التعويضات الأكثر تنافسية في الصناعة. إذا كانت لديك أي أسئلة، فلا تتردد في الاتصال بنا: [email protected]
لمزيد من التفاصيل حول Yaohai Bio-Pharma، يرجى الرجوع إلى الموقع الإلكتروني: www.yaohaibio-pharma.com
المنتجات الموصى بها
احدث الموضوعات
-
اجتازت شركة Yaohai Bio-Pharma عملية تدقيق الجودة في الاتحاد الأوروبي وحصلت على شهادة ISO الثلاثية
2024-05-08
-
بوابة التكنولوجيا الحيوية، على الانترنت
2024-05-13
-
المؤتمر العالمي للقاحات 2024 واشنطن
2024-04-01
-
CPHI أمريكا الشمالية 2024
2024-05-07
-
الاتفاقية الدولية للبيوتكنولوجيا 2024
2024-06-03
-
مستحضرات التجميل FCE
2024-06-04
-
سي بي إتش آي ميلان 2024
2024-10-08